OncoImmunology Oncoimmunology, 8, e1631119 OncoImmunology, Vol 8, Iss 10 (2019) Oncoimmunology, 8, 10, pp. e1631119 Oncoimmunology Gonzalez, M L, Oosterhoff, D, Lindenberg, J J, Milenova, I, Lougheed, S M, Martianez, T, Dekker, H, Quixabeira, D C A, Hangalapura, B, Joore, J, Piersma, S R, Cervera-Carrascon, V, Santos, J M, Scheper, R J, Verheul, H M W, Jimenez, C R, Van De Ven, R, Hemminki, A, Van Beusechem, V W & De Gruijl, T D 2019, ' Constitutively active GSK3β as a means to bolster dendritic cell functionality in the face of tumour-mediated immune suppression ', OncoImmunology, vol. 8, no. 10 . https://doi.org/10.1080/2162402X.2019.1631119 OncoImmunology, 8(10). Landes Bioscience
Human Vaccines & Immunotherapeutics, 10(6), 1622-1632. Landes Bioscience Lindenberg, J J, van de Ven, R, Oosterhoff, D, Sombroek, C C, Lougheed, S M, Stam, A G M, Koenen, H J P M, van den Eertwegh, A J M, Scheper, R J & de Gruijl, T D 2014, ' Induction of dendritic cell maturation in the skin microenvironment by soluble factors derived from colon carcinoma ', Human Vaccines & Immunotherapeutics, vol. 10, no. 6, pp. 1622-1632 . https://doi.org/10.4161/hv.28548 Human Vaccines & Immunotherapeutics, 10, 6, pp. 1622-32 Human Vaccines & Immunotherapeutics, 10, 1622-32
van de Ven, R, Lindenberg, J J, Reurs, A W, Scheper, R J, Scheffer, G L & de Gruijl, T D 2012, ' Preferential Langerhans cell differentiation from CD34(+) precursors upon introduction of ABCG2 (BCRP). ', Immunology and cell biology, vol. 90, no. 2, pp. 206-215 . https://doi.org/10.1038/icb.2011.25 Immunology and cell biology, 90(2), 206-215. Springer Nature
Journal of Immunotherapy, 32(9), 895-906. Lippincott Williams and Wilkins van de Ven, R, Lindenberg, J J, Oosterhoff, D, van den Tol, M P, Rosalia, R A, Murakami, M, Everts, M, Scheffer, G L, Scheper, R J, de Gruijl, T D & Curiel, D T 2009, ' Selective Transduction of Mature DC in Human Skin and Lymph Nodes by CD80/CD86-targeted Fiber-modified Adenovirus-5/3 ', Journal of Immunotherapy, vol. 32, no. 9, pp. 895-906 . https://doi.org/10.1097/CJI.0b013e3181b56deb
OncoImmunology, 1(5), 649-658. Landes Bioscience Oncoimmunology Oosterhoff, D, Lougheed, S M, van de Ven, R, Lindenberg, J J, van Cruijsen, H, Hiddingh, L, Kroon, J, van den Eertwegh, A J M, Hangalapura, B, Scheper, R J & de Gruijl, T D 2012, ' Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition ', OncoImmunology, vol. 1, no. 5, pp. 649-658 . https://doi.org/10.4161/onci.20365 Oncoimmunology, 2012, 649-658 Oncoimmunology, 2012, Aug 1; 1(5), pp. 649-658
Immunotherapy, 3(1), 77-96. Future Medicine Ltd. Lindenberg, J J, Fehres, C M, van Cruijsen, H, Oosterhoff, D & de Gruijl, T D 2011, ' Cross-talk between tumor and myeloid cells: how to tip the balance in favor of antitumor immunity ', Immunotherapy, vol. 3, no. 1, pp. 77-96 . https://doi.org/10.2217/imt.10.95
van Cruijsen, H, Oosterhoff, D, Lindenberg, J J, Lougheed, S M, Fehres, C M, Weijers, K, van Boerdonk, R A A, Giaccone, G, Scheper, R J, Hoekman, K & de Gruijl, T D 2011, ' Glioblastoma-induced inhibition of Langerhans cell differentiation from CD34(+) precursors is mediated by IL-6 but unaffected by JAK2/STAT3 inhibition. ', Immunotherapy, vol. 3, no. 9, pp. 1051-1061 . https://doi.org/10.2217/IMT.11.107 Immunotherapy, 3(9), 1051-1061. Future Medicine Ltd.
Pegtel, D M, Cosmopoulos, K, Thorley-Lawson, DA, van Eijndhoven, M A J, Hopmans, E S, Lindenberg, J J, de Gruijl, T D, Würdinger, T & Middeldorp, J M 2010, ' Functional delivery of viral miRNAs via exosomes ', Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 14, pp. 6328-6333 . https://doi.org/10.1073/pnas.0914843107 Proceedings of the National Academy of Sciences of the United States of America, 107(14), 6328-6333. National Academy of Sciences
Clinical Immunology, 136(3), 364-374. Academic Press Inc. Clinical Immunology, 136, 3, pp. 364-74 Bontkes, H J, Moreno Jauge, M, Hangalapura, B N, Lindenberg, J J, de Groot, J, Lougheed, S M, van der Vliet, J J, van den Eertwegh, A J M, de Gruijl, T D, von Blomberg, B M E & Scheper, R J 2010, ' Attenuation of invariant Natural Killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide ', Clinical Immunology, vol. 136, no. 3, pp. 364-374 . https://doi.org/10.1016/j.clim.2010.04.019 Clinical Immunology, 136, 364-74